Anti‐tumour necrosis factor therapy associated with cutaneous vasculitis

Anti‐tumour necrosis factor therapy associated with cutaneous vasculitis

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) Vol. 41; no. 12; pp. 1450 - 1452
Main Authors: Livermore, P. A., Murray, K. J.
Format: Journal Article
Language:English
Published: Oxford Oxford University Press 01-12-2002
Oxford Publishing Limited (England)
Subjects:
Antirheumatic Agents - therapeutic use
Arthritis, Juvenile - drug therapy
Biological and medical sciences
Child
Drug Therapy, Combination
Drug toxicity and drugs side effects treatment
Etanercept
Female
Glucocorticoids - therapeutic use
Histamine H1 Antagonists - therapeutic use
Humans
Immunoglobulin G - adverse effects
Immunoglobulin G - therapeutic use
Medical sciences
Methotrexate - therapeutic use
Miscellaneous (drug allergy, mutagens, teratogens...)
Pharmacology. Drug treatments
Prednisolone - therapeutic use
Receptors, Tumor Necrosis Factor - therapeutic use
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Vasculitis, Leukocytoclastic, Cutaneous - chemically induced
Human
Skin disease
Toxicity
Diseases of the osteoarticular system
Cardiovascular disease
Juvenile rheumatoid arthritis
Inflammatory joint disease
Vascular disease
Case study
Immunomodulator
Chemotherapy
Chronic
Treatment
Vasculitis
Etanercept
Anticytokine
Capillary vessel disease
Skin
Child
Tumor necrosis factor α
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ark:/67375/HXZ-78QB7R4X-J
istex:64D77E4D0D76A73522A888E994C45054D18D6F44
PII:1460-2172
local:411450
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/41.12.1450